Niemann-Pick B - RS - 5th infusion.

Biomolecules, Free Full-Text

Interstitial lung disease in lysosomal storage disorders

Natural history and management of liver dysfunction in lysosomal storage disorders

Niemann-Pick Disease

Familial Hypercholesterolemia: From Clinical Suspicion to Novel Treatments

Frontiers Potential Disease-Modifying Effects of Lithium Carbonate in Niemann-Pick Disease, Type C1

Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial - The Lancet

Necroptosis in Niemann–Pick disease, type C1: a potential therapeutic target

Lysosomal storage diseases: Diagnostic confirmation and management of presymptomatic individuals

Olipudase alfa enzyme replacement therapy for acid sphingomyelinase deficiency (ASMD): sustained improvements in clinical outcomes after 6.5 years of treatment in adults, Orphanet Journal of Rare Diseases

Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial - The Lancet

Current Clinical Applications of In Vivo Gene Therapy with AAVs: Molecular Therapy